Showing results (161-170 of 6,751) with videos related to

Sort By:
Pageof 676
European Journal of Endocrinology|June 24, 2006
The effects of sex-steroid administration on the pituitary-thyroid axis in transsexualsPeter H Bisschop, Arno W Toorians, Erik Endert, et al.
European Journal of Endocrinology|June 24, 2006
Perchlorate versus other environmental sodium/iodide symporter inhibitors: potential thyroid-related health effectsBert De Groef, Brigitte R Decallonne, Serge Van der Geyten, et al.
European Journal of Endocrinology|June 24, 2006
A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral densityJosé A Riancho, María T Zarrabeitia, Carmen Valero, et al.
European Journal of Endocrinology|June 24, 2006
Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysisRoger Abs, Ulla Feldt-Rasmussen, Anders F Mattsson, et al.
European Journal of Endocrinology|June 24, 2006
GH secretory pattern in young adults who discontinued GH treatment for GH deficiency and decreased longitudinal growth in childhoodJohan Svensson, Gudmundur Johannsson, Ali Iranmanesh, et al.
European Journal of Endocrinology|June 24, 2006
Serum leptin and C-reactive protein levels in the physiological spontaneous menstrual cycle in reproductive age womenD M Wunder, M Yared, N A Bersinger, et al.
European Journal of Endocrinology|May 27, 2006
Smoking and autoimmune thyroid disease: the plot thickensGerasimos E Krassas, Wilmar Wiersinga
European Journal of Endocrinology|May 27, 2006
Immunohistochemical investigation of angiogenic factors in parathyroid proliferative lesionsAndreas C Lazaris, Sofia Tseleni-Balafouta, Thomas Papathomas, et al.
European Journal of Endocrinology|May 27, 2006
Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and GermanyBernhard Saller, Anders F Mattsson, Peter H Kann, et al.
European Journal of Endocrinology|May 27, 2006
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetesD Kapoor, E Goodwin, K S Channer, et al.
Pageof 676